Microsampling for pharmacokinetic bioanalysis with Hua Li
AI-Enhanced Medicine Pill Concept for Future Healthcare. Pill symbolizing integration of artificial intelligence in the development of future healthcare and advanced treatments
In this interview we caught up with Hua Li (Boehringer Ingelheim Pharmaceuticals, CT, USA). In 2018 Li authored a methodology article published in Bioanalysis titled 'Application of Mitra® microsampling for pharmacokinetic bioanalysis of monoclonal antibodies in rats.' When we spoke to Hua, she told us about the inspiration for this research and discussed the importance of PK/PD scientists in the early phases of drug development. Want to stay up-to-date with the latest news and gain access to exclusive journal articles? "I majored in Biotechnology in college back in China and then earned a Master’s degree in Molecular, Cellular and Developmental...
